IMVT EBITDA Growth
Immunovant Inc · EBITDA Growth
IMVT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-28.04%period ending
IMVT Quarterly EBITDA YoY % (-21.80% → -28.04%)
Year-over-year change
High-resolution chart · PNG
IMVT ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -28.0443% | |
| -42.4057% | |
| 1.7038% | |
| -15.4664% | |
| -37.4743% | |
| -40.9661% | |
| -115.4173% | |
| -87.3573% | |
| -17.7252% | |
| -24.274% | |
| 18.0328% | |
| -22.1142% | |
| -84.8438% | |
| -28.0524% | |
| -51.8451% | |
| -26.2955% | |
| -31.1323% | |
| -67.0884% | |
| -30.7739% | |
| -79.895% | |
| -14.7125% | |
| -36.9394% | |
| -192.381% | |
| -4,953.5615% | |
| -30,327.5148% | |
| -4,578,566.6667% | |
| -21.7969% |